The PaceNew therapies / indications available since the last 12 months 
Olumiant
BY: Olive TseSep 17, 2021

Olumiant
(baricitinib) Eli Lilly

 

Composition:
• Available in film-coated tablet with each contains 2 mg or 4 mg baricitinib

 

Indications:
• Newly indicated for the treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic therapy

• Also indicated as monotherapy or in combination with methotrexate for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs

 

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.

You May Be Interested In
Venclexta
BY: Olive TseJun 15, 2020
Duraphat
BY: Ai Ly FooAug 11, 2023
Erleada
BY: Olive TseDec 15, 2020
INVEGA HAFYERA
BY: Winnie TangFeb 6, 2024